191 related articles for article (PubMed ID: 6895934)
41. Failure of the cholinergic modulation of norepinephrine release during acute myocardial ischemia in the rat.
Du XJ; Dart AM; Riemersma RA; Oliver MF
Circ Res; 1990 Apr; 66(4):950-6. PubMed ID: 2180589
[TBL] [Abstract][Full Text] [Related]
42. Presynaptic receptor systems on the noradrenergic neurones of the rabbit pulmonary artery.
Endo T; Starke K; Bangerter A; Taube HD
Naunyn Schmiedebergs Arch Pharmacol; 1977 Feb; 296(3):229-47. PubMed ID: 840318
[TBL] [Abstract][Full Text] [Related]
43. Altered cardiac adrenergic neurotransmission in streptozotocin-induced diabetic rats.
Gando S; Hattori Y; Kanno M
Br J Pharmacol; 1993 Aug; 109(4):1276-81. PubMed ID: 8401939
[TBL] [Abstract][Full Text] [Related]
44. Muscarinic receptors in rat nasal mucosa are predominantly of the low affinity agonist type.
Rodrigues de Miranda JF; Scheres HM; Salden HJ; Beld AJ; Klaassen AB; Kuijpers W
Eur J Pharmacol; 1985 Jul; 113(3):441-5. PubMed ID: 3840092
[TBL] [Abstract][Full Text] [Related]
45. Presynaptic muscarinic receptor subtypes involved in the inhibition of acetylcholine and noradrenaline release in bovine cerebral arteries.
Ferrer M; Galván R; Marín J; Balfagón G
Naunyn Schmiedebergs Arch Pharmacol; 1992 Jun; 345(6):619-26. PubMed ID: 1635587
[TBL] [Abstract][Full Text] [Related]
46. The binding of pirenzepine to digitonin-solubilized muscarinic acetylcholine receptors from the rat myocardium.
Birdsall NJ; Hulme EC; Keen M
Br J Pharmacol; 1986 Feb; 87(2):307-16. PubMed ID: 3754173
[TBL] [Abstract][Full Text] [Related]
47. Muscarinic receptors in the stomach.
Hammer R
Scand J Gastroenterol Suppl; 1980; 66():5-11. PubMed ID: 6941378
[TBL] [Abstract][Full Text] [Related]
48. Involvement of presynaptic imidazoline receptors in the alpha 2-adrenoceptor-independent inhibition of noradrenaline release by imidazoline derivatives.
Göthert M; Molderings GJ
Naunyn Schmiedebergs Arch Pharmacol; 1991 Mar; 343(3):271-82. PubMed ID: 1678140
[TBL] [Abstract][Full Text] [Related]
49. Presynaptic imidazoline receptors and non-adrenoceptor [3H]-idazoxan binding sites in human cardiovascular tissues.
Molderings GJ; Likungu J; Jakschik J; Göthert M
Br J Pharmacol; 1997 Sep; 122(1):43-50. PubMed ID: 9298527
[TBL] [Abstract][Full Text] [Related]
50. Heterogeneity of presynaptic muscarinic receptors involved in modulation of transmitter release.
Vizi ES; Kobayashi O; Töröcsik A; Kinjo M; Nagashima H; Manabe N; Goldiner PL; Potter PE; Foldes FF
Neuroscience; 1989; 31(1):259-67. PubMed ID: 2549449
[TBL] [Abstract][Full Text] [Related]
51. Presynaptic control of noradrenaline release from sympathetic nerves in human dental pulp.
Parker DA; de la Lande IS; Marino V; Ivar PM
Arch Oral Biol; 1994 Jan; 39(1):35-41. PubMed ID: 7910015
[TBL] [Abstract][Full Text] [Related]
52. A unique regulatory profile and regional distribution of [3H]pirenzepine binding in the rat provide evidence for distinct M1 and M2 muscarinic receptor subtypes.
Watson M; Yamamura HI; Roeske WR
Life Sci; 1983 Jun; 32(26):3001-11. PubMed ID: 6688111
[TBL] [Abstract][Full Text] [Related]
53. Binding profile of a novel cardioselective muscarine receptor antagonist, AF-DX 116, to membranes of peripheral tissues and brain in the rat.
Hammer R; Giraldo E; Schiavi GB; Monferini E; Ladinsky H
Life Sci; 1986 May; 38(18):1653-62. PubMed ID: 3754610
[TBL] [Abstract][Full Text] [Related]
54. Interaction between the release of adenosine and noradrenaline during sympathetic stimulation: a feed-back mechanism in rat heart.
Richardt G; Waas W; Kranzhöfer R; Cheng B; Lohse MJ; Schömig A
J Mol Cell Cardiol; 1989 Mar; 21(3):269-77. PubMed ID: 2568492
[TBL] [Abstract][Full Text] [Related]
55. Presence of muscarinic inhibitory and absence of nicotinic excitatory receptors at the terminal sympathetic nerves of chicken hearts.
Engel U; Löffelholz K
Naunyn Schmiedebergs Arch Pharmacol; 1976 Dec; 295(3):225-30. PubMed ID: 1012343
[TBL] [Abstract][Full Text] [Related]
56. Pharmacological characterization of muscarine receptors of PC12 (rat phaeochromocytoma) cells.
Bönisch H; Boer R; Dobler M; Schudt C
Naunyn Schmiedebergs Arch Pharmacol; 1990 Mar; 341(3):158-64. PubMed ID: 2342599
[TBL] [Abstract][Full Text] [Related]
57. Pharmacological analysis of muscarinic receptors coupled to oxyntic cell secretion in the mouse stomach.
Black JW; Shankley NP
Br J Pharmacol; 1985 Nov; 86(3):601-7. PubMed ID: 2866004
[TBL] [Abstract][Full Text] [Related]
58. Differential effects of acidosis, high potassium concentrations, and metabolic inhibition on noradrenaline release and its presynaptic muscarinic regulation.
Haunstetter A; Schulze Icking B; Backs J; Krüger C; Haass M
Pharmacol Res; 2002 Mar; 45(3):221-8. PubMed ID: 11884219
[TBL] [Abstract][Full Text] [Related]
59. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
Watson M; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580
[TBL] [Abstract][Full Text] [Related]
60. Selectivity profile of the novel muscarinic antagonist UH-AH 37 determined by the use of cloned receptors and isolated tissue preparations.
Wess J; Lambrecht G; Mutschler E; Brann MR; Dörje F
Br J Pharmacol; 1991 Jan; 102(1):246-50. PubMed ID: 2043926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
